VIOKASE PWR
VIOKASE PWR
Discontinued
DIN Number
01910493
Drug Class
Human
Market Date
Dec 31, 1991
Company
HC
ayerst laboratories
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01910493
AIG Number0302964006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Product Specifications
Dosage FormPowder
Route of AdministrationOral
AHFS Classification56:16.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
AMYLASEActive
Strength: 70000 UNIT / 700 MG
Monograph: AMYLASE
LIPASEActive
Strength: 16800 UNIT / 700 MG
Monograph: LIPASE
PROTEASEActive
Strength: 70000 UNIT / 700 MG
Monograph: PROTEASE